Report Detail
Global Cancer (Tumor) Profiling Market Professional Survey Report 2019
- RnM3785262 |
- 26 September, 2019 |
- Global |
- 107 Pages |
- QYResearch |
- Pharma & Healthcare
The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology.
Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2017.
The global Cancer (Tumor) Profiling market was valued at 5260 million US$ in 2018 and will reach 12100 million US$ by the end of 2025, growing at a CAGR of 11.0% during 2019-2025.
This report focuses on Cancer (Tumor) Profiling volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer (Tumor) Profiling market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer (Tumor) Profiling in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer (Tumor) Profiling manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Illumina
Qiagen
Neogenomics Laboratories
HTG Molecular Diagnostics
Genomic Health
Caris Life Sciences
Helomics Corporation
Nanostring Technologies
Oxford Gene Technology
Ribomed Biotechnologies
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Immunoassay
Hybridization
NGS
Mass Spectrometry
Segment by Application
Clinical
Research
Table of Contents
Executive Summary
1 Industry Overview of Cancer (Tumor) Profiling
- 1.1 Definition of Cancer (Tumor) Profiling
- 1.2 Cancer (Tumor) Profiling Segment by Type
- 1.2.1 Global Cancer (Tumor) Profiling Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Immunoassay
- 1.2.3 Hybridization
- 1.2.4 NGS
- 1.2.5 Mass Spectrometry
- 1.3 Cancer (Tumor) Profiling Segment by Applications
- 1.3.1 Global Cancer (Tumor) Profiling Consumption Comparison by Applications (2014-2025)
- 1.3.2 Clinical
- 1.3.3 Research
- 1.4 Global Cancer (Tumor) Profiling Overall Market
- 1.4.1 Global Cancer (Tumor) Profiling Revenue (2014-2025)
- 1.4.2 Global Cancer (Tumor) Profiling Production (2014-2025)
- 1.4.3 North America Cancer (Tumor) Profiling Status and Prospect (2014-2025)
- 1.4.4 Europe Cancer (Tumor) Profiling Status and Prospect (2014-2025)
- 1.4.5 China Cancer (Tumor) Profiling Status and Prospect (2014-2025)
- 1.4.6 Japan Cancer (Tumor) Profiling Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Cancer (Tumor) Profiling Status and Prospect (2014-2025)
- 1.4.8 India Cancer (Tumor) Profiling Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Cancer (Tumor) Profiling
- 2.3 Manufacturing Process Analysis of Cancer (Tumor) Profiling
- 2.4 Industry Chain Structure of Cancer (Tumor) Profiling
3 Development and Manufacturing Plants Analysis of Cancer (Tumor) Profiling
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Cancer (Tumor) Profiling Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Cancer (Tumor) Profiling
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Cancer (Tumor) Profiling Production and Capacity Analysis
- 4.2 Cancer (Tumor) Profiling Revenue Analysis
- 4.3 Cancer (Tumor) Profiling Price Analysis
- 4.4 Market Concentration Degree
5 Cancer (Tumor) Profiling Regional Market Analysis
- 5.1 Cancer (Tumor) Profiling Production by Regions
- 5.1.1 Global Cancer (Tumor) Profiling Production by Regions
- 5.1.2 Global Cancer (Tumor) Profiling Revenue by Regions
- 5.2 Cancer (Tumor) Profiling Consumption by Regions
- 5.3 North America Cancer (Tumor) Profiling Market Analysis
- 5.3.1 North America Cancer (Tumor) Profiling Production
- 5.3.2 North America Cancer (Tumor) Profiling Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Cancer (Tumor) Profiling Import and Export
- 5.4 Europe Cancer (Tumor) Profiling Market Analysis
- 5.4.1 Europe Cancer (Tumor) Profiling Production
- 5.4.2 Europe Cancer (Tumor) Profiling Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Cancer (Tumor) Profiling Import and Export
- 5.5 China Cancer (Tumor) Profiling Market Analysis
- 5.5.1 China Cancer (Tumor) Profiling Production
- 5.5.2 China Cancer (Tumor) Profiling Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Cancer (Tumor) Profiling Import and Export
- 5.6 Japan Cancer (Tumor) Profiling Market Analysis
- 5.6.1 Japan Cancer (Tumor) Profiling Production
- 5.6.2 Japan Cancer (Tumor) Profiling Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Cancer (Tumor) Profiling Import and Export
- 5.7 Southeast Asia Cancer (Tumor) Profiling Market Analysis
- 5.7.1 Southeast Asia Cancer (Tumor) Profiling Production
- 5.7.2 Southeast Asia Cancer (Tumor) Profiling Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Cancer (Tumor) Profiling Import and Export
- 5.8 India Cancer (Tumor) Profiling Market Analysis
- 5.8.1 India Cancer (Tumor) Profiling Production
- 5.8.2 India Cancer (Tumor) Profiling Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Cancer (Tumor) Profiling Import and Export
6 Cancer (Tumor) Profiling Segment Market Analysis (by Type)
- 6.1 Global Cancer (Tumor) Profiling Production by Type
- 6.2 Global Cancer (Tumor) Profiling Revenue by Type
- 6.3 Cancer (Tumor) Profiling Price by Type
7 Cancer (Tumor) Profiling Segment Market Analysis (by Application)
- 7.1 Global Cancer (Tumor) Profiling Consumption by Application
- 7.2 Global Cancer (Tumor) Profiling Consumption Market Share by Application (2014-2019)
8 Cancer (Tumor) Profiling Major Manufacturers Analysis
- 8.1 Illumina
- 8.1.1 Illumina Cancer (Tumor) Profiling Production Sites and Area Served
- 8.1.2 Illumina Product Introduction, Application and Specification
- 8.1.3 Illumina Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Qiagen
- 8.2.1 Qiagen Cancer (Tumor) Profiling Production Sites and Area Served
- 8.2.2 Qiagen Product Introduction, Application and Specification
- 8.2.3 Qiagen Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Neogenomics Laboratories
- 8.3.1 Neogenomics Laboratories Cancer (Tumor) Profiling Production Sites and Area Served
- 8.3.2 Neogenomics Laboratories Product Introduction, Application and Specification
- 8.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 HTG Molecular Diagnostics
- 8.4.1 HTG Molecular Diagnostics Cancer (Tumor) Profiling Production Sites and Area Served
- 8.4.2 HTG Molecular Diagnostics Product Introduction, Application and Specification
- 8.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genomic Health
- 8.5.1 Genomic Health Cancer (Tumor) Profiling Production Sites and Area Served
- 8.5.2 Genomic Health Product Introduction, Application and Specification
- 8.5.3 Genomic Health Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Caris Life Sciences
- 8.6.1 Caris Life Sciences Cancer (Tumor) Profiling Production Sites and Area Served
- 8.6.2 Caris Life Sciences Product Introduction, Application and Specification
- 8.6.3 Caris Life Sciences Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Helomics Corporation
- 8.7.1 Helomics Corporation Cancer (Tumor) Profiling Production Sites and Area Served
- 8.7.2 Helomics Corporation Product Introduction, Application and Specification
- 8.7.3 Helomics Corporation Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Nanostring Technologies
- 8.8.1 Nanostring Technologies Cancer (Tumor) Profiling Production Sites and Area Served
- 8.8.2 Nanostring Technologies Product Introduction, Application and Specification
- 8.8.3 Nanostring Technologies Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Oxford Gene Technology
- 8.9.1 Oxford Gene Technology Cancer (Tumor) Profiling Production Sites and Area Served
- 8.9.2 Oxford Gene Technology Product Introduction, Application and Specification
- 8.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Ribomed Biotechnologies
- 8.10.1 Ribomed Biotechnologies Cancer (Tumor) Profiling Production Sites and Area Served
- 8.10.2 Ribomed Biotechnologies Product Introduction, Application and Specification
- 8.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Cancer (Tumor) Profiling Market
- 9.1 Global Cancer (Tumor) Profiling Market Trend Analysis
- 9.1.1 Global Cancer (Tumor) Profiling Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Cancer (Tumor) Profiling Regional Market Trend
- 9.2.1 North America Cancer (Tumor) Profiling Forecast 2019-2025
- 9.2.2 Europe Cancer (Tumor) Profiling Forecast 2019-2025
- 9.2.3 China Cancer (Tumor) Profiling Forecast 2019-2025
- 9.2.4 Japan Cancer (Tumor) Profiling Forecast 2019-2025
- 9.2.5 Southeast Asia Cancer (Tumor) Profiling Forecast 2019-2025
- 9.2.6 India Cancer (Tumor) Profiling Forecast 2019-2025
- 9.3 Cancer (Tumor) Profiling Market Trend (Product Type)
- 9.4 Cancer (Tumor) Profiling Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Cancer (Tumor) Profiling Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Cancer (Tumor) Profiling. Industry analysis & Market Report on Cancer (Tumor) Profiling is a syndicated market report, published as Global Cancer (Tumor) Profiling Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cancer (Tumor) Profiling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
